Cargando…

Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC

OBJECTIVES: To compare the inter-modality consistency and diagnostic performances of the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) and contrast-enhanced computed tomography (CECT) LI-RADS in patients at risk for hepatocellular carcinoma (HCC), so as to hel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Rong, Huang, Weiche, Song, Rui, Qin, Lanhui, Wu, Yuquan, Peng, Yuting, Huang, Xiongyan, He, Yun, Yang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496202/ https://www.ncbi.nlm.nih.gov/pubmed/37697248 http://dx.doi.org/10.1186/s12880-023-01088-1

Ejemplares similares

CEUS LI-RADS: a pictorial review
por: Bartolotta, Tommaso Vincenzo, et al.
Publicado: (2020)

Differentiating malignant and benign focal liver lesions in children using CEUS LI-RADS combined with serum alpha-fetoprotein
por: Jiang, Zhen-Peng, et al.
Publicado: (2022)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Can Risk Stratification Based on Ultrasound Elastography of Background Liver Assist CEUS LI-RADS in the Diagnosis of HCC?
por: Li, Jiawu, et al.
Publicado: (2021)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

Structured Reporting Using CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma (HCC)—Impact and Advantages on Report Integrity, Quality and Interdisciplinary Communication
por: Geyer, Thomas, et al.
Publicado: (2021)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
por: Zhou, Yan, et al.
Publicado: (2022)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study
por: Strobel, D., et al.
Publicado: (2021)

Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk
por: Tong, Wen-juan, et al.
Publicado: (2022)

Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update
por: Granata, Vincenza, et al.
Publicado: (2017)

Diagnostic Value of CEUS LI-RADS Version 2017 in Differentiating AFP-Negative Hepatocellular Carcinoma from Other Primary Malignancies of the Liver
por: Wang, Peihua, et al.
Publicado: (2021)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm)
por: Ling, Wenwu, et al.
Publicado: (2018)

Comparison of machine learning models and CEUS LI-RADS in differentiation of hepatic carcinoma and liver metastases in patients at risk of both hepatitis and extrahepatic malignancy
por: Li, Jianming, et al.
Publicado: (2023)

Standardizing liver imaging reporting and interpretation: LI-RADS and beyond
por: Rich, Nicole E., et al.
Publicado: (2023)

Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
por: Kim, Tae Kyoung, et al.
Publicado: (2017)

Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

Correction to: Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

LI-RADS v2017 for liver nodules: how we read and report
por: Schima, Wolfgang, et al.
Publicado: (2018)

A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls
por: De Muzio, Federica, et al.
Publicado: (2022)

CT/MRI LI-RADS v2017 – review of the guidelines
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

US LI-RADS visualization score: diagnostic outcome of ultrasound-guided focal hepatic lesion biopsy in patients at risk for hepatocellular carcinoma
por: Kang, Ji Hun, et al.
Publicado: (2021)

Comparison of LI-RADS v.2017 and ESGAR Guidelines Imaging Criteria in HCC Diagnosis Using MRI with Hepatobiliary Contrast Agents
por: Rosiak, Grzegorz, et al.
Publicado: (2018)

Interrater reliability and agreement of the liver imaging reporting and data system (LI-RADS) v2018 for the evaluation of hepatic lesions
por: Abdelrahman, Ahmed S., et al.
Publicado: (2022)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
por: Li, Yubo, et al.
Publicado: (2023)

CT-MRI LI-RADS v2017: A Comprehensive Guide for Beginners
por: Patella, Francesca, et al.
Publicado: (2018)

Major and Ancillary Features According to LI-RADS in the Assessment of Combined Hepatocellular-cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2020)

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
por: Voizard, Nicolas, et al.
Publicado: (2019)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
por: Liu, Xinai, et al.
Publicado: (2022)

Fully automating LI-RADS on MRI with deep learning-guided lesion segmentation, feature characterization, and score inference
por: Wang, Ke, et al.
Publicado: (2023)

Comparison of multiphase data from CT perfusion vs clinical 4-phase CT scans with respect to image quality, lesion detection, and LI-RADS classification in HCC patients
por: Mohammadi, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_09t3q2dr7kcaptq3ka59ul2mo6